NCT02821221: Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects |
|
|
| Recruiting | 3 | 250 | RoW | Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®), IMOJEV® | National Institute of Hygiene and Epidemiology, Vietnam, Sanofi Pasteur, a Sanofi Company | Japanese Encephalitis | 03/16 | 12/16 | | |
NCT02821195: Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine |
|
|
| Recruiting | 3 | 354 | RoW | DTaP-IPV-Hep B-PRP-T combined vaccine, Hexaxim™ | National Institute of Hygiene and Epidemiology, Vietnam, Sanofi Pasteur, a Sanofi Company | Diphtheria, Tetanus, Pertussis, Poliomyelitis, Hepatitis B, Haemophilus Influenzae Type b Infection | 12/16 | 03/17 | | |